Experience and outcomes of the first Movement Disorders Clinic in Honduras.
Objective: To describe the frequency and clinical characteristics using standardized scales in patients with movement disorders (MD) recruited by a referral system in Tegucigalpa, Honduras.…Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation
Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation. Background: Most patients…The influence of sleep disordered breathing in REM sleep behavior disorder associated symptoms
Objective: To compare the intensity of non-motor symptoms between REM sleep behavioral disorder (RBD) patients with and without Obstructive Sleep Apnea (OSA). Background: In RBD…Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease
Objective: To utilize free speech characteristics to develop markers of motor and cognitive status in Parkinson’s disease (PD). Background: Vocal biomarkers based on speech volume,…Gastroesophageal dysmotility in advanced Parkinson’s Disease
Objective: The aim of this study is to evaluate the patterns of gastroparesis in PD patients with motor fluctuations and dyskinesias. Background: Gastrointestinal dysfunction is…Validation of the performance based Erlangen Test of Activities of Daily Living in PD
Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with…The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease
Objective: The aim of this study was to investigate the relationship between the degree of olfactory function and motor subtype of Parkinson's disease (PD). Background:…Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…Non-motor symptoms in the first neurology consultation in Cali – Colombia
Objective: To describe the distribution of NMS of PD in patients assisted by the Outpatient Neurology Service between 2012 and 2016 in a high level hospital…To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population
Objective: To study the role of serum DJ-1 and Apo A1 in the diagnosis and differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes(PPS)…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 155
- Next Page »